Minggu, 07 Oktober 2007

Arthritis in Children

JUVENILE CHRONIC ARTHRITIS (JCA)

Approximately 1:1000 children will develop swelling of one or more joints persisting for more than 3 months with no specific cause found. 50% of these will progress to JCA.

Aetiology - unknown

Diagnostic Criteria

  • Age under 16 at onset
  • Persistent arthritis in one or more joints for 6 weeks (minimum) to 3 months after other aetiologies have been ruled out. E.g. infection, malignancy, blood dyscrasias, Reiter's, hypogammaglobulinaemia

Classification by onset (Schaller)

1. Systemic onset (Still's disease)

  • Age: usually under 5years but can be any age
  • Sex: <5yr female =" male;">5yr female > male
  • Fever (high with spikes up to 40oC daily) plus one of the following
  1. Maculopapular rash
  2. Iridocyclitis
  3. RhF +ve
  4. Cervical spine involvement
  5. Pericarditis
  • Generalised lymphadenopathy
  • Hepatomegaly
  • Splenomegaly
  • Sites: knees, wrists, ankle, feet

2. Polyarticular onset

  • Age: any, even before age 1year!
  • Sex: female > male
  • 5 or more joints involved in the first 3 months
  • Seronegative (RhFactor -ve)
  • Seronegative (RhFactor -ve)

Sites: knees (60%), wrists, hands

  • RhFactor +ve

Older children (9-10 years) with persistent activity and rapid joint destruction affecting mainly the hands and feet.

3. Pauciarticular (most common)

  • 4 or less joints involved in the first 3 months
  • Type I
  • Type I

Younger onset <6yr,>

  • Type II

Older onset 9yr+, with males mainly affected. Association with HLA-B27.


Lab tests


HB

WCC

ESR

RhF

ANA

Systemic

-

++

++

+ve

+ve

Polyarticular

+

+

+

-/+ve

30%+ve (in those with RhF+ve)

Pauciarticular

-

-

+ or -

-ve

-ve (M) +ve (F)


Radiological changes

  • Early features limited to periarticular osteopenia
  • Late features occur after 6 months and include growth disturbance, chondrolysis, joint destruction and erosions. These features are more common in the RhF +ve patients.

Prognosis

  • 80% will eventually be able to lead normal functional lives.
  • Death can occasionally occur in the systemic onset group because of infection or the development of amyloidosis.
  • 60% if seen within 1 year of onset will have normal function at 5 years compared with 25% of those seen after 1 year.
  • Functional outcome is related to joint contractures and destruction.

Poor prognostic factors

  • Onset <>
  • IgM (RhF) +ve
  • Eye involvement
  • Hip involvement leads to a greater functional deficit

Medical Management

  • Aim: to suppress activity and therefore prevent joint deformity
  • Multidisciplinary approach with rheumatologist, PT, OT, child psychologist etc
  • PT to help prevent joint contractures and keep healthy muscles working. Hydrotherapy affective.
  • OT for splints and orthoses

Drug treatment

  • NSAID's
    • Ibuprofen, voltarol, naproxen etc.
    • Aspirin used to be the drug of choice but dangerous with children under the age of 5 years because of the risk of Reye's syndrome.
  • Disease modifying drugs
    • Methotrexate: shown to be effective in polyarticular disease
    • Gold, penicillamine, azathioprine etc.
  • Corticosteroids
    • Systemic: the use of steroids does not affect the ultimate prognosis and there are many complications related to their use, in particular growth disturbance, adrenal suppression etc.
    • Intra-articular/tendon sheath: can be effective in controlling flare ups

Surgical treatment

  • Hip
    • Soft tissue releases for contractures
    • Total joint replacement
  • Knee
    • Soft tissue releases for contractures
    • Synovectomy
    • Epiphyseal stapling
    • Supra-condylar osteotomy
    • Total joint replacement (rarely needed)
  • Foot and ankle
    • Orthoses
    • Triple fusion

Summary

Type

%

Joints

Features

Progression (%)

Systemic (Still's)

25

many

Fever, rash, organomegaly

25

Polyarticular: RhF -ve

15

many

Mild fever

30

Polyarticular: RhF+ve

15

many

Severe joint destruction

25

Pauciarticular I (F)

30

large

Iridocyclitis

15

Pauciarticular II (M)

15

large

Spondylitis, HLA-B27

15


Other arthritides

  • Juvenile psoriatic arthropathy
  • Ankylosing spondylitis
  • Reiter's disease
  • Acute rheumatic fever

Tidak ada komentar: